Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Mark Wood. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Mark Wood har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:BMRN / BioMarin Pharmaceutical Inc. | VP, Human Resources | 16 150 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Mark Wood. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Mark Wood som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2013-05-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −520 | 16 150 | −3,12 | |||
2013-05-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | X | −812 | 15 339 | −5,03 | |||
2013-05-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −833 | 5 837 | −12,49 | |||
2013-05-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −938 | 0 | −100,00 | |||
2013-05-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 103 | 20 277 | −13,27 | 67,12 | −208 283 | 1 361 055 |
2013-05-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 520 | 23 380 | 2,27 | 37,46 | 19 479 | 875 815 |
2013-05-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 812 | 22 860 | 3,68 | 26,49 | 21 510 | 605 561 |
2013-05-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 833 | 22 048 | 3,93 | 21,51 | 17 918 | 474 252 |
2013-05-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 938 | 21 215 | 4,63 | 14,39 | 13 498 | 305 284 |
2013-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 258 | 20 277 | −10,02 | 67,68 | −152 821 | 1 372 347 | |
2013-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 305 | 22 535 | −5,47 | 65,32 | −85 243 | 1 471 986 | |
2013-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 595 | 23 840 | 2,56 | 27,90 | 16 603 | 665 255 | |
2013-04-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −520 | 19 275 | −2,63 | |||
2013-04-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | X | −812 | 20 317 | −3,84 | |||
2013-04-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −833 | 10 837 | −7,14 | |||
2013-04-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −937 | 938 | −49,97 | |||
2013-04-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 102 | 23 245 | −11,77 | 65,57 | −203 413 | 1 524 286 |
2013-04-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 520 | 26 347 | 2,01 | 37,46 | 19 479 | 986 959 |
2013-04-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 812 | 25 827 | 3,25 | 26,49 | 21 510 | 684 157 |
2013-04-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 833 | 25 015 | 3,44 | 21,51 | 17 918 | 538 073 |
2013-04-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 937 | 24 182 | 4,03 | 14,39 | 13 483 | 347 979 |
2013-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −520 | 19 795 | −2,56 | 37,46 | −19 479 | 741 521 |
2013-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | X | −812 | 21 129 | −3,70 | |||
2013-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −833 | 11 670 | −6,66 | |||
2013-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −938 | 1 875 | −33,35 | |||
2013-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 103 | 23 245 | −11,78 | 60,21 | −186 821 | 1 399 505 |
2013-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 520 | 26 348 | 2,01 | 37,46 | 19 479 | 986 996 |
2013-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 812 | 25 828 | 3,25 | 26,49 | 21 510 | 684 184 |
2013-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 833 | 25 016 | 3,44 | 21,51 | 17 918 | 538 094 |
2013-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 938 | 24 183 | 4,04 | 14,39 | 13 498 | 347 993 |
2013-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −834 | 57 570 | −1,43 | |||
2013-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −937 | 58 404 | −1,58 | |||
2013-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | X | −812 | 59 343 | −1,35 | |||
2013-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −520 | 60 155 | −0,86 | 37,46 | −19 479 | 2 253 406 |
2013-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −520 | 23 245 | −2,19 | 55,00 | −28 600 | 1 278 475 |
2013-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 583 | 23 765 | −9,80 | 55,26 | −142 744 | 1 313 318 |
2013-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 834 | 26 348 | 3,27 | 21,51 | 17 939 | 566 745 |
2013-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 812 | 25 514 | 3,29 | 26,49 | 21 510 | 675 866 |
2013-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 937 | 24 702 | 3,94 | 14,39 | 13 483 | 355 462 |
2013-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 520 | 23 765 | 2,24 | 37,46 | 19 479 | 890 237 |
2013-02-13 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
P - Purchase | 588 | 23 245 | 2,60 | 27,91 | 16 408 | 648 663 | |
2013-02-13 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −459 | 22 657 | −1,99 | 37,99 | −17 437 | 860 739 | |
2013-02-13 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 589 | 23 116 | −6,43 | 38,00 | −60 382 | 878 408 | |
2013-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −833 | 60 675 | −1,35 | |||
2013-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −939 | 61 508 | −1,50 | |||
2013-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | X | −812 | 62 447 | −1,28 | |||
2013-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −4 165 | 63 259 | −6,18 | 37,46 | −156 021 | 2 369 682 |
2013-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −40 000 | 67 424 | −37,24 | 38,59 | −1 543 600 | 2 601 892 |
2013-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −44 165 | 25 646 | −63,26 | 55,00 | −2 429 075 | 1 410 530 |
2013-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 584 | 69 811 | −3,57 | 54,81 | −141 627 | 3 826 278 |
2013-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 833 | 72 395 | 1,16 | 21,51 | 17 918 | 1 557 216 |
2013-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 812 | 71 562 | 1,15 | 26,49 | 21 510 | 1 895 677 |
2013-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 939 | 70 750 | 1,35 | 14,39 | 13 512 | 1 018 092 |
2013-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 40 000 | 69 811 | 134,18 | 38,59 | 1 543 600 | 2 694 006 |
2013-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 4 165 | 29 811 | 16,24 | 37,46 | 156 021 | 1 116 720 |
2012-12-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −833 | 107 424 | −0,77 | |||
2012-12-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −941 | 108 257 | −0,86 | |||
2012-12-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −170 | 109 198 | −0,16 | |||
2012-12-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | X | −812 | 109 368 | −0,74 | |||
2012-12-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 756 | 25 646 | −9,70 | 49,32 | −135 927 | 1 264 871 |
2012-12-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 833 | 28 402 | 3,02 | 21,51 | 17 918 | 610 927 |
2012-12-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 812 | 27 569 | 3,03 | 26,49 | 21 510 | 730 303 |
2012-12-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 170 | 26 757 | 0,64 | 17,86 | 3 036 | 477 880 |
2012-12-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 941 | 26 587 | 3,67 | 14,39 | 13 541 | 382 587 |
2012-12-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −7 659 | 25 646 | −23,00 | 49,11 | −376 159 | 1 259 560 | |
2012-11-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −833 | 110 180 | −0,75 | |||
2012-11-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −937 | 111 013 | −0,84 | |||
2012-11-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −83 | 111 950 | −0,07 | |||
2012-11-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −812 | 112 033 | −0,72 | |||
2012-11-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 665 | 32 364 | −7,61 | 48,92 | −130 367 | 1 583 192 |
2012-11-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 833 | 35 029 | 2,44 | 21,51 | 17 918 | 753 474 |
2012-11-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 937 | 34 196 | 2,82 | 14,39 | 13 483 | 492 080 |
2012-11-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 83 | 33 259 | 0,25 | 17,86 | 1 482 | 594 006 |
2012-11-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 812 | 33 176 | 2,51 | 26,49 | 21 510 | 878 832 |
2012-10-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −833 | 112 845 | −0,73 | |||
2012-10-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −937 | 113 678 | −0,82 | |||
2012-10-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −83 | 114 615 | −0,07 | |||
2012-10-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −812 | 114 698 | −0,70 | |||
2012-10-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 665 | 32 364 | −7,61 | 41,86 | −111 554 | 1 354 721 |
2012-10-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 833 | 35 029 | 2,44 | 21,51 | 17 918 | 753 474 |
2012-10-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 937 | 34 196 | 2,82 | 14,39 | 13 483 | 492 080 |
2012-10-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 83 | 33 259 | 0,25 | 17,86 | 1 482 | 594 006 |
2012-10-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 812 | 33 176 | 2,51 | 26,49 | 21 510 | 878 832 |
2012-09-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −833 | 115 510 | −0,72 | |||
2012-09-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −937 | 116 343 | −0,80 | |||
2012-09-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −83 | 117 280 | −0,07 | |||
2012-09-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −812 | 117 363 | −0,69 | |||
2012-09-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 665 | 32 364 | −7,61 | 40,48 | −107 878 | 1 310 082 |
2012-09-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 833 | 35 029 | 2,44 | 21,51 | 17 918 | 753 474 |
2012-09-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 937 | 34 196 | 2,82 | 14,39 | 13 483 | 492 080 |
2012-09-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 83 | 33 259 | 0,25 | 17,86 | 1 482 | 594 006 |
2012-09-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 812 | 33 176 | 2,51 | 26,49 | 21 510 | 878 832 |
2012-08-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −833 | 118 175 | −0,70 | |||
2012-08-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −937 | 119 008 | −0,78 | |||
2012-08-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −83 | 119 945 | −0,07 | |||
2012-08-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −813 | 120 028 | −0,67 | |||
2012-08-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 853 | 32 364 | −5,42 | 37,90 | −70 233 | 1 226 673 |
2012-08-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 833 | 34 217 | 2,50 | 21,51 | 17 918 | 736 008 |
2012-08-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 937 | 33 384 | 2,89 | 14,39 | 13 483 | 480 396 |
2012-08-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 83 | 32 447 | 0,26 | 17,86 | 1 482 | 579 503 |
2012-08-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −812 | 32 364 | −2,45 | 38,00 | −30 856 | 1 229 832 |
2012-08-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 812 | 33 176 | 2,51 | 26,49 | 21 510 | 878 832 |
2012-07-25 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −833 | 120 840 | −0,68 | |||
2012-07-25 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −937 | 121 673 | −0,76 | |||
2012-07-25 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −83 | 122 610 | −0,07 | |||
2012-07-25 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −813 | 122 693 | −0,66 | |||
2012-07-25 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 666 | 32 364 | −7,61 | 39,25 | −104 633 | 1 270 200 |
2012-07-25 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 833 | 35 030 | 2,44 | 21,51 | 17 918 | 753 495 |
2012-07-25 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 937 | 34 197 | 2,82 | 14,39 | 13 483 | 492 095 |
2012-07-25 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 83 | 33 260 | 0,25 | 17,86 | 1 482 | 594 024 |
2012-07-25 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 813 | 33 177 | 2,51 | 26,49 | 21 536 | 878 859 |
2012-06-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −812 | 123 506 | −0,65 | 26,49 | −21 510 | 3 271 674 |
2012-06-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −812 | 32 364 | −2,45 | 38,00 | −30 856 | 1 229 832 |
2012-06-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 812 | 33 176 | 2,51 | 26,49 | 21 510 | 878 832 |
2012-06-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −833 | 124 318 | −0,67 | 21,51 | −17 918 | 2 674 080 |
2012-06-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −937 | 125 151 | −0,74 | 14,39 | −13 483 | 1 800 923 |
2012-06-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −83 | 126 088 | −0,07 | 17,86 | −1 482 | 2 251 932 |
2012-06-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 853 | 32 364 | −5,42 | 36,83 | −68 245 | 1 191 947 |
2012-06-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 833 | 34 217 | 2,50 | 21,51 | 17 918 | 736 008 |
2012-06-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 937 | 33 384 | 2,89 | 14,39 | 13 483 | 480 396 |
2012-06-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 83 | 32 447 | 0,26 | 17,86 | 1 482 | 579 503 |
2012-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Restricted Stock Units |
M - Exercise | −1 250 | 18 650 | −6,28 | ||||
2012-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 1 250 | 32 364 | 4,02 | ||||
2012-05-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −813 | 126 171 | −0,64 | 26,49 | −21 536 | 3 342 270 |
2012-05-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −833 | 126 984 | −0,65 | 21,51 | −17 918 | 2 731 426 |
2012-05-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −937 | 127 817 | −0,73 | 14,39 | −13 483 | 1 839 287 |
2012-05-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −83 | 128 754 | −0,06 | 17,86 | −1 482 | 2 299 546 |
2012-05-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 666 | 31 114 | −7,89 | 38,01 | −101 333 | 1 182 621 |
2012-05-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 813 | 33 780 | 2,47 | 26,49 | 21 536 | 894 832 |
2012-05-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 833 | 32 967 | 2,59 | 21,51 | 17 918 | 709 120 |
2012-05-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 937 | 32 134 | 3,00 | 14,39 | 13 483 | 462 408 |
2012-05-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 83 | 31 197 | 0,27 | 17,86 | 1 482 | 557 178 |
2012-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to bu) Common Stock |
M - Exercise | X | −2 437 | 128 837 | −1,86 | 17,86 | −43 525 | 2 301 029 |
2012-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 437 | 31 114 | −7,26 | 38,00 | −92 606 | 1 182 332 |
2012-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 437 | 33 551 | 7,83 | 26,49 | 64 556 | 888 766 |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
A - Award | 25 000 | 131 274 | 23,52 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | −10 000 | 31 114 | −24,32 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 480 | 21 114 | 2,33 | 27,91 | 13 395 | 589 207 | |
2012-04-25 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −833 | 106 274 | −0,78 | 21,51 | −17 918 | 2 285 954 |
2012-04-25 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −937 | 107 107 | −0,87 | 14,39 | −13 483 | 1 541 270 |
2012-04-25 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to bu) Common Stock |
M - Exercise | X | −83 | 108 044 | −0,08 | 17,86 | −1 482 | 1 929 666 |
2012-04-25 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 853 | 20 634 | −8,24 | 34,54 | −64 006 | 712 733 |
2012-04-25 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 833 | 22 487 | 3,85 | 21,51 | 17 918 | 483 695 |
2012-04-25 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 937 | 21 654 | 4,52 | 14,39 | 13 483 | 311 601 |
2012-04-25 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 83 | 20 717 | 0,40 | 17,86 | 1 482 | 370 006 |
2012-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −833 | 108 127 | −0,76 | 21,51 | −17 918 | 2 325 812 |
2012-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −938 | 108 960 | −0,85 | 14,39 | −13 498 | 1 567 934 |
2012-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to bu) Common Stock |
M - Exercise | X | −84 | 109 898 | −0,08 | 17,86 | −1 500 | 1 962 778 |
2012-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 855 | 20 634 | −8,25 | 35,65 | −66 139 | 735 697 |
2012-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 833 | 22 489 | 3,85 | 21,51 | 17 918 | 483 738 |
2012-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 938 | 21 656 | 4,53 | 14,39 | 13 498 | 311 630 |
2012-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 84 | 20 718 | 0,41 | 17,86 | 1 500 | 370 023 |
2012-02-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −834 | 109 982 | −0,75 | 21,51 | −17 939 | 2 365 713 |
2012-02-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −937 | 110 816 | −0,84 | 14,39 | −13 483 | 1 594 642 |
2012-02-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to bu) Common Stock |
M - Exercise | X | −83 | 111 753 | −0,07 | 17,86 | −1 482 | 1 995 909 |
2012-02-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 854 | 20 634 | −8,24 | 35,14 | −65 149 | 725 073 |
2012-02-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 834 | 22 488 | 3,85 | 21,51 | 17 939 | 483 717 |
2012-02-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 937 | 21 654 | 4,52 | 14,39 | 13 483 | 311 601 |
2012-02-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 83 | 20 717 | 0,40 | 17,86 | 1 482 | 370 006 |
2012-02-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −6 500 | 111 836 | −5,49 | 26,49 | −172 185 | 2 962 536 |
2012-02-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −6 500 | 20 634 | −23,96 | 38,00 | −247 000 | 784 092 |
2012-02-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 6 500 | 27 134 | 31,50 | 26,49 | 172 185 | 718 780 |
2012-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −833 | 118 336 | −0,70 | 21,51 | −17 918 | 2 545 407 |
2012-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −938 | 119 169 | −0,78 | 14,39 | −13 498 | 1 714 842 |
2012-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to bu) Common Stock |
M - Exercise | X | −83 | 120 107 | −0,07 | 17,86 | −1 482 | 2 145 111 |
2012-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 854 | 20 634 | −8,24 | 34,96 | −64 821 | 721 427 |
2012-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 833 | 22 488 | 3,85 | 21,51 | 17 918 | 483 717 |
2012-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 938 | 21 655 | 4,53 | 14,39 | 13 498 | 311 615 |
2012-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 83 | 20 717 | 0,40 | 17,86 | 1 482 | 370 006 |
2010-06-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −372 | 14 243 | −2,55 | 19,79 | −7 362 | 281 878 |
2010-06-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −470 | 14 615 | −3,12 | 18,87 | −8 868 | 275 765 |
2010-06-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 1 000 | 15 085 | 7,10 | ||||
2010-06-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Restricted Stock Units |
M - Exercise | −1 000 | 3 500 | −22,22 | ||||
2010-06-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Restricted Stock Units |
M - Exercise | −1 250 | 4 500 | −21,74 | ||||
2010-06-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 1 250 | 14 085 | 9,74 |